Your browser doesn't support javascript.
loading
Pembrolizumab versus methotrexate, docetaxel, or cetuximab in recurrent or metastatic head and neck squamous cell carcinoma (KEYNOTE-040): Subgroup analysis by pattern of disease recurrence.
Harrington, K J; Cohen, E E W; Soulières, D; Dinis, J; Licitra, L; Ahn, M-J; Soria, A; Machiels, J-P; Mach, N; Mehra, R; Burtness, B; Swaby, R F; Lin, J; Ge, J; Lerman, N; Tourneau, C Le.
Affiliation
  • Harrington KJ; 105 Cotswold Road, Division of Radiotherapy and Imaging, The Institute of Cancer Research/The Royal Marsden NHS Foundation Trust National Institute of Health Research Biomedical Research Centre, London SM2 5NG, United Kingdom. Electronic address: Kevin.Harrington@icr.ac.uk.
  • Cohen EEW; 3855 Health Sciences Dr, Department of Medical Oncology, Moores Cancer Center, UC San Diego Health, La Jolla, CA 92093, United States. Electronic address: ecohen@ucsd.edu.
  • Soulières D; 1560, rue Sherbrooke estx, Department of Hematology and Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, QC H2L 4MN, Canada. Electronic address: denis.soulieres.chum@ssss.gouv.qc.ca.
  • Dinis J; R Dr. Antonio Bernardino de Almeida Medicina Oncologica Unidade de Investigacao Clinica, Department of Medical Oncology, Instituto Português de Oncologia do Porto Francisco Gentil, 4200-072 Porto, Portugal. Electronic address: jdinis@ipoporto.min-saude.pt.
  • Licitra L; Via Giacomo Venezian, 1, Department of Head and Neck Cancer, Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, 20133 Milan, Italy.
  • Ahn MJ; 81 Irwon-Ro Gangnam, Department of Hematology & Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, South Korea.
  • Soria A; Ctra. de Colmenar Viejo km. 9,100, Department of Medical Oncology, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.
  • Machiels JP; Avenue Hippocrate 10, Department of Medical Oncology, Institut Roi Albert II, Cliniques Universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale, Université Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium.
  • Mach N; Rue Gabrielle-Perret-Gentil 4, Clinical Research Unit, Department of Oncology, Hôpitaux Universitaires de Genève, 1205 Geneva, Switzerland.
  • Mehra R; 22 South Greene Street, Department of Head and Neck Medical Oncology, Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD 21201, United States.
  • Burtness B; 25 York Street PO Box 208028, Yale Cancer Center and Department of Medicine, Yale University School of Medicine, New Haven, CT 06510, United States.
  • Swaby RF; 90 E Scott Ave, Merck & Co., Inc., Rahway, NJ 07065, United States.
  • Lin J; 90 E Scott Ave, Merck & Co., Inc., Rahway, NJ 07065, United States.
  • Ge J; 90 E Scott Ave, Merck & Co., Inc., Rahway, NJ 07065, United States.
  • Lerman N; 90 E Scott Ave, Merck & Co., Inc., Rahway, NJ 07065, United States.
  • Tourneau CL; 26 rue d'Ulm, Department of Drug Development and Innovation (D3i), Institut Curie, Paris-Saclay University, 75005 Paris, France.
Oral Oncol ; 147: 106587, 2023 Dec.
Article in En | MEDLINE | ID: mdl-37925894
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Methotrexate / Head and Neck Neoplasms Limits: Humans Language: En Journal: Oral Oncol Journal subject: NEOPLASIAS Year: 2023 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Methotrexate / Head and Neck Neoplasms Limits: Humans Language: En Journal: Oral Oncol Journal subject: NEOPLASIAS Year: 2023 Document type: Article Country of publication: